On December 21, 2023, Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. closed the transaction. The company has received CNY 50 million and the company's registered capital is subscribed by CNY 906,594 and the remaining is included in capital reserve.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.55 CNY | +1.67% | +1.85% | +7.24% |
1st Jan change | Capi. | |
---|---|---|
+7.24% | 685M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- 600479 Stock
- News ZhuZhou QianJin Pharmaceutical Co.,Ltd
- Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it has received CNY 50 million in funding from a group of investors